Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock, Voting	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2020	$ 343,486	$ 21,989	$ 246,890	$ 66,879	$ 7,728
Beginning balance, shares at Dec. 31, 2020		21,988,803
Net issuance of restricted common stock activity	(98)	$ 118	(216)
Net issuance of restricted common stock activity, shares		117,962
Stock-based compensation expense	349		349
Net exercise of common stock options		$ 1	(1)
Net exercise of common stock options, shares		1,039
Repurchase of common stock	(462)	$ (27)	(435)
Repurchase of common stock, shares		(27,260)
Common stock dividends declared	(1,093)			(1,093)
Net income	11,030			11,030
Other comprehensive loss	(9,425)				(9,425)
Ending balance at Mar. 31, 2021	343,787	$ 22,081	246,587	76,816	(1,697)
Ending balance, shares at Mar. 31, 2021		22,080,544
Beginning balance at Dec. 31, 2020	343,486	$ 21,989	246,890	66,879	7,728
Beginning balance, shares at Dec. 31, 2020		21,988,803
Net income	23,106
Other comprehensive loss	(5,647)
Ending balance at Jun. 30, 2021	359,752	$ 22,166	247,945	87,560	2,081
Ending balance, shares at Jun. 30, 2021		22,165,547
Beginning balance at Mar. 31, 2021	343,787	$ 22,081	246,587	76,816	(1,697)
Beginning balance, shares at Mar. 31, 2021		22,080,544
Net issuance of restricted common stock activity	(30)	$ (3)	(27)
Net issuance of restricted common stock activity, shares		(2,926)
Stock-based compensation expense	447		447
Net exercise of common stock options	1,026	$ 88	938
Net exercise of common stock options, shares		87,929
Common stock dividends declared	(1,332)			(1,332)
Net income	12,076			12,076
Other comprehensive loss	3,778				3,778
Ending balance at Jun. 30, 2021	359,752	$ 22,166	247,945	87,560	2,081
Ending balance, shares at Jun. 30, 2021		22,165,547
Beginning balance at Dec. 31, 2021	380,094	$ 22,166	248,709	110,489	(1,270)
Beginning balance, shares at Dec. 31, 2021		22,166,129
Net issuance of restricted common stock activity	(87)	$ 66	(153)
Net issuance of restricted common stock activity, shares		65,550
Stock-based compensation expense	388		388
Repurchase of common stock	(767)	$ (37)	(730)
Repurchase of common stock, shares		(36,608)
Common stock dividends declared	(1,320)			(1,320)
Net income	10,673			10,673
Other comprehensive loss	(20,064)				(20,064)
Ending balance at Mar. 31, 2022	368,917	$ 22,195	248,214	119,842	(21,334)
Ending balance, shares at Mar. 31, 2022		22,195,071
Beginning balance at Dec. 31, 2021	$ 380,094	$ 22,166	248,709	110,489	(1,270)
Beginning balance, shares at Dec. 31, 2021		22,166,129
Net exercise of common stock options, shares	5,800
Net income	$ 20,645
Other comprehensive loss	(34,056)
Ending balance at Jun. 30, 2022	357,735	$ 21,934	243,497	127,630	(35,326)
Ending balance, shares at Jun. 30, 2022		21,934,554
Beginning balance at Mar. 31, 2022	368,917	$ 22,195	248,214	119,842	(21,334)
Beginning balance, shares at Mar. 31, 2022		22,195,071
Net issuance of restricted common stock activity		$ (4)	4
Net issuance of restricted common stock activity, shares		(3,719)
Stock-based compensation expense	325		325
Net exercise of common stock options	51	$ 6	45
Net exercise of common stock options, shares		5,800
Repurchase of common stock	(5,354)	$ (263)	(5,091)
Repurchase of common stock, shares		(262,598)
Common stock dividends declared	(2,184)			(2,184)
Net income	9,972			9,972
Other comprehensive loss	(13,992)				(13,992)
Ending balance at Jun. 30, 2022	$ 357,735	$ 21,934	$ 243,497	$ 127,630	$ (35,326)
Ending balance, shares at Jun. 30, 2022		21,934,554